Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianjun Yu

Showing results (1-10 of 420) with videos related to

Pageof 42
Sort By:
Seminars in Oncology|January 7, 2019
Selecting chemotherapy for pancreatic cancer: Far away or so close?Si Shi, Xianjun Yu
Annals of Surgery|November 16, 2019
Comment on "Operable Pancreatic Cancer: Are We in an Era of Individualized Neoadjuvant Therapy?"Jie Hua, Si Shi, Xianjun Yu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2020
Neoadjuvant Treatment for Pancreatic Cancer: Still a Controversial Issue?Si Shi, Jie Hua, Xianjun Yu
Autophagy Reports|May 21, 2025
NLRP4 drives olaparib resistance in pancreatic cancerMingming Xiao, Xianjun Yu, Si Shi
JAMA Surgery|December 27, 2019
Prognostic Value of Pancreatic Fistula in Resected Patients With Pancreatic Cancer With Neoadjuvant TherapySi Shi, Jie Hua, Xianjun Yu
Gastroenterology|May 26, 2026
Reply to Jiang and ZhaoZhilong Ma, Xianjun Yu, Si Shi
Annals of Surgical Oncology|October 13, 2019
Outcomes of Lymph Node Dissection for Nonmetastatic Pancreatic Neuroendocrine Tumors: To Dissect or Not To DissectJie Hua, Si Shi, Xianjun Yu
Chinese Clinical Oncology|May 10, 2019
Understanding genetic features of pancreatic neoplasmJin He, Zhi-Gang Zhang, Xianjun Yu
Annals of Surgical Oncology|August 21, 2019
ASO Author Reflections: Resection for Metastasis to the Pancreas-Worthwhile for Selected PatientsQiuyi Huang, Haiyang Zhou, Chen Liu, et al.
Frontiers of Medicine|December 11, 2012
The epidemic status and risk factors of lung cancer in Xuanwei City, Yunnan Province, ChinaYize Xiao, Ying Shao, Xianjun Yu, et al.
Pageof 42

Showing results (1-10 of 420) with videos related to

Sort By:
Pageof 42
Seminars in Oncology|January 7, 2019
Selecting chemotherapy for pancreatic cancer: Far away or so close?Si Shi, Xianjun Yu
Annals of Surgery|November 16, 2019
Comment on "Operable Pancreatic Cancer: Are We in an Era of Individualized Neoadjuvant Therapy?"Jie Hua, Si Shi, Xianjun Yu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2020
Neoadjuvant Treatment for Pancreatic Cancer: Still a Controversial Issue?Si Shi, Jie Hua, Xianjun Yu
Autophagy Reports|May 21, 2025
NLRP4 drives olaparib resistance in pancreatic cancerMingming Xiao, Xianjun Yu, Si Shi
JAMA Surgery|December 27, 2019
Prognostic Value of Pancreatic Fistula in Resected Patients With Pancreatic Cancer With Neoadjuvant TherapySi Shi, Jie Hua, Xianjun Yu
Gastroenterology|May 26, 2026
Reply to Jiang and ZhaoZhilong Ma, Xianjun Yu, Si Shi
Annals of Surgical Oncology|October 13, 2019
Outcomes of Lymph Node Dissection for Nonmetastatic Pancreatic Neuroendocrine Tumors: To Dissect or Not To DissectJie Hua, Si Shi, Xianjun Yu
Chinese Clinical Oncology|May 10, 2019
Understanding genetic features of pancreatic neoplasmJin He, Zhi-Gang Zhang, Xianjun Yu
Annals of Surgical Oncology|August 21, 2019
ASO Author Reflections: Resection for Metastasis to the Pancreas-Worthwhile for Selected PatientsQiuyi Huang, Haiyang Zhou, Chen Liu, et al.
Frontiers of Medicine|December 11, 2012
The epidemic status and risk factors of lung cancer in Xuanwei City, Yunnan Province, ChinaYize Xiao, Ying Shao, Xianjun Yu, et al.
Pageof 42